Opus Genetics IRD
NASDAQ IRD
$4.66 +0.07 (+1.41%)
As of: Sep 4, 2026 · 3:15 PM EDT

Opus Genetics (IRD) Tax Rate (2022 - 2025)

Opus Genetics (IRD) posted quarterly Tax Rate of 63.03% for Q4 2025, up 151070.97% quarter-over-quarter from 0.04% in Q4 2023.

Analysis

Opus Genetics (IRD) Tax Rate (2022 - 2025) Analysis & Trends

Opus Genetics (IRD) has reported Tax Rate for 3 consecutive years, with 63.03% the latest figure, recorded in Q4 2025.

  • In Q4 2025, Tax Rate changed N/A year-over-year to 63.03%; the TTM figure through Mar 2026 stood at 9.74% (changed N/A YoY), while the FY2025 annual figure was 21.0%, changed N/A from the prior year.
  • Tax Rate rose to 63.03% in Q4 2025 per IRD's latest filing, from 0.04% in the prior quarter.
  • Across five years, Tax Rate topped out at 63.03% in Q4 2025 and bottomed at 0.04% in Q4 2023.
  • Historically, Tax Rate has averaged 16.06% across 3 years, with a median of 0.59% in 2023.
  • On a YoY basis, Tax Rate climbed as much as 88 bps in 2023 and fell as far as 88 bps in 2023.
  • Opus Genetics' Tax Rate stood at 0.92% in 2022, then tumbled by 95 bps to 0.04% in 2023, then surged by 151071 bps to 63.03% in 2025.
  • Business Quant data shows IRD's Tax Rate at 63.03% in Q4 2025, 0.04% in Q4 2023, and 0.25% in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 15.11%
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -10.89%
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -1.96%
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 24.15%
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 7.49%
8 Royalty Pharma 28.43 Bn 27.59 Bn - -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.71%
10 Opus Genetics 447.34 Mn 358.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 63.03%
Dec 31, 2023 0.04%
Sep 30, 2023 0.25%
Dec 31, 2022 0.92%